Multi-omic rejuvenation of human cells by maturation phase transient reprogramming

  1. Diljeet Gill
  2. Aled Parry
  3. Fátima Santos
  4. Hanneke Okkenhaug
  5. Christopher D Todd
  6. Irene Hernando-Herraez
  7. Thomas M Stubbs
  8. Inês Milagre  Is a corresponding author
  9. Wolf Reik  Is a corresponding author
  1. Babraham Institute, United Kingdom
  2. Chronomics Limited, United Kingdom
  3. Instituto Gulbenkian de Ciência, Portugal
  4. Altos Labs, United Kingdom

Abstract

Ageing is the gradual decline in organismal fitness that occurs over time leading to tissue dysfunction and disease. At the cellular level, ageing is associated with reduced function, altered gene expression and a perturbed epigenome. Somatic cell reprogramming, the process of converting somatic cells to induced pluripotent stem cells (iPSCs), can reverse these age-associated changes. However, during iPSC reprogramming, somatic cell identity is lost, and can be difficult to reacquire as re-differentiated iPSCs often resemble foetal rather than mature adult cells. Recent work has demonstrated that the epigenome is already rejuvenated by the maturation phase of reprogramming, which suggests full iPSC reprogramming is not required to reverse ageing of somatic cells. Here we have developed the first 'maturation phase transient reprogramming' (MPTR) method, where reprogramming factors are expressed until this rejuvenation point followed by withdrawal of their induction. Using dermal fibroblasts from middle age donors, we found that cells temporarily lose and then reacquire their fibroblast identity during MPTR, possibly as a result of epigenetic memory at enhancers and/or persistent expression of some fibroblast genes. Excitingly, our method substantially rejuvenated multiple cellular attributes including the transcriptome, which was rejuvenated by around 30 years as measured by a novel transcriptome clock. The epigenome, including H3K9me3 histone methylation levels and the DNA methylation ageing clock, was rejuvenated to a similar extent. The magnitude of rejuvenation instigated by MTPR appears substantially greater than that achieved in previous transient reprogramming protocols. In addition, MPTR fibroblasts produced youthful levels of collagen proteins, and showed partial functional rejuvenation of their migration speed. Finally, our work suggests that more extensive reprogramming does not necessarily result in greater rejuvenation but instead that optimal time windows exist for rejuvenating the transcriptome and the epigenome. Overall, we demonstrate that it is possible to separate rejuvenation from complete pluripotency reprogramming, which should facilitate the discovery of novel anti-ageing genes and therapies.

Data availability

DNA methylation array and RNA-seq data are available on Gene Expression Omnibus under the accession number: GSE165180.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Diljeet Gill

    Epigenetics Programme, Babraham Institute, Cambridge, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5725-2466
  2. Aled Parry

    Epigenetics Programme, Babraham Institute, Cambridge, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5192-3727
  3. Fátima Santos

    Epigenetics Programme, Babraham Institute, Cambridge, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3854-4084
  4. Hanneke Okkenhaug

    Imaging Facility, Babraham Institute, Cambridge, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0669-4069
  5. Christopher D Todd

    Epigenetics Programme, Babraham Institute, Cambridge, United Kingdom
    Competing interests
    No competing interests declared.
  6. Irene Hernando-Herraez

    Epigenetics Programme, Babraham Institute, Cambridge, United Kingdom
    Competing interests
    No competing interests declared.
  7. Thomas M Stubbs

    Chronomics Limited, Norwich, United Kingdom
    Competing interests
    Thomas M Stubbs, is CEO and shareholder of Chronomics.
  8. Inês Milagre

    Laboratory for Epigenetic Mechanisms, Instituto Gulbenkian de Ciência, Oeiras, Portugal
    For correspondence
    imilagre@igc.gulbenkian.pt
    Competing interests
    No competing interests declared.
  9. Wolf Reik

    Altos Labs, Cambridge, United Kingdom
    For correspondence
    wolf.reik@babraham.ac.uk
    Competing interests
    Wolf Reik, is a consultant and shareholder of Cambridge Epigenetix. Is employed by Altos Labs..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0216-9881

Funding

Biotechnology and Biological Sciences Research Council

  • Diljeet Gill
  • Fátima Santos
  • Hanneke Okkenhaug
  • Christopher D Todd
  • Irene Hernando-Herraez
  • Thomas M Stubbs
  • Inês Milagre
  • Wolf Reik

Wellcome Trust

  • Aled Parry

Milky Way Research Foundation

  • Diljeet Gill
  • Wolf Reik

Wellcome Investigator award (210754/Z/18/Z)

  • Wolf Reik

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2022, Gill et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 76,167
    views
  • 8,969
    downloads
  • 100
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Diljeet Gill
  2. Aled Parry
  3. Fátima Santos
  4. Hanneke Okkenhaug
  5. Christopher D Todd
  6. Irene Hernando-Herraez
  7. Thomas M Stubbs
  8. Inês Milagre
  9. Wolf Reik
(2022)
Multi-omic rejuvenation of human cells by maturation phase transient reprogramming
eLife 11:e71624.
https://doi.org/10.7554/eLife.71624

Share this article

https://doi.org/10.7554/eLife.71624

Further reading

    1. Cell Biology
    2. Genetics and Genomics
    Adam D Longhurst, Kyle Wang ... David P Toczyski
    Tools and Resources

    Progression through the G1 phase of the cell cycle is the most highly regulated step in cellular division. We employed a chemogenetic approach to discover novel cellular networks that regulate cell cycle progression. This approach uncovered functional clusters of genes that altered sensitivity of cells to inhibitors of the G1/S transition. Mutation of components of the Polycomb Repressor Complex 2 rescued proliferation inhibition caused by the CDK4/6 inhibitor palbociclib, but not to inhibitors of S phase or mitosis. In addition to its core catalytic subunits, mutation of the PRC2.1 accessory protein MTF2, but not the PRC2.2 protein JARID2, rendered cells resistant to palbociclib treatment. We found that PRC2.1 (MTF2), but not PRC2.2 (JARID2), was critical for promoting H3K27me3 deposition at CpG islands genome-wide and in promoters. This included the CpG islands in the promoter of the CDK4/6 cyclins CCND1 and CCND2, and loss of MTF2 lead to upregulation of both CCND1 and CCND2. Our results demonstrate a role for PRC2.1, but not PRC2.2, in antagonizing G1 progression in a diversity of cell linages, including chronic myeloid leukemia (CML), breast cancer, and immortalized cell lines.

    1. Genetics and Genomics
    Nathan M Shugarts Devanapally, Aishwarya Sathya ... Antony M Jose
    Research Article

    RNAs in circulation carry sequence-specific regulatory information between cells in plant, animal, and host-pathogen systems. Such RNA can cross generational boundaries, as evidenced by somatic double-stranded RNA (dsRNA) in the nematode Caenorhabditis elegans silencing genes of matching sequence in progeny. Here we dissect the intergenerational path taken by dsRNA from parental circulation and discover that cytosolic import through the dsRNA importer SID-1 in the parental germline and/or developing progeny varies with developmental time and dsRNA substrates. Loss of SID-1 enhances initiation of heritable RNA silencing within the germline and causes changes in the expression of the sid-1-dependent gene sdg-1 that last for more than 100 generations after restoration of SID-1. The SDG-1 protein is enriched in perinuclear germ granules required for heritable RNA silencing but is expressed from a retrotransposon targeted by such silencing. This auto-inhibitory loop suggests how retrotransposons could persist by hosting genes that regulate their own silencing.